172 related articles for article (PubMed ID: 38032932)
1. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
[TBL] [Abstract][Full Text] [Related]
2. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
Elife; 2018 Mar; 7():. PubMed ID: 29547122
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex.
Liao JM; Zhou X; Gatignol A; Lu H
Oncogene; 2014 Oct; 33(41):4916-23. PubMed ID: 24141778
[TBL] [Abstract][Full Text] [Related]
4. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein S14 negatively regulates c-Myc activity.
Zhou X; Hao Q; Liao JM; Liao P; Lu H
J Biol Chem; 2013 Jul; 288(30):21793-801. PubMed ID: 23775087
[TBL] [Abstract][Full Text] [Related]
6. RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.
Cao Y; Geng J; Wang X; Meng Q; Xu S; Lang Y; Zhou Y; Qi L; Wang Z; Wei Z; Yu Y; Jin S; Pan B
Int J Biol Sci; 2022; 18(1):124-139. PubMed ID: 34975322
[TBL] [Abstract][Full Text] [Related]
7. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of c-Myc activity by ribosomal protein L11.
Dai MS; Arnold H; Sun XX; Sears R; Lu H
EMBO J; 2007 Jul; 26(14):3332-45. PubMed ID: 17599065
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression.
Dai MS; Sun XX; Lu H
J Biol Chem; 2010 Apr; 285(17):12587-94. PubMed ID: 20194507
[TBL] [Abstract][Full Text] [Related]
12. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.
Jung JH; Lee H; Cao B; Liao P; Zeng SX; Lu H
Oncogene; 2020 Jan; 39(5):1031-1040. PubMed ID: 31591476
[TBL] [Abstract][Full Text] [Related]
13. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
14. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Ciribilli Y; Singh P; Inga A; Borlak J
Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
16. RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
Loiselle JJ; Roy JG; Sutherland LC
PLoS One; 2017; 12(6):e0180258. PubMed ID: 28662214
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
18. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Cao B; Fang Z; Liao P; Zhou X; Xiong J; Zeng S; Lu H
Oncotarget; 2017 Oct; 8(53):90651-90661. PubMed ID: 29207594
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.
Challagundla KB; Sun XX; Zhang X; DeVine T; Zhang Q; Sears RC; Dai MS
Mol Cell Biol; 2011 Oct; 31(19):4007-21. PubMed ID: 21807902
[TBL] [Abstract][Full Text] [Related]
20. Functional role of RBM10 in lung adenocarcinoma proliferation.
Sun X; Jia M; Sun W; Feng L; Gu C; Wu T
Int J Oncol; 2019 Feb; 54(2):467-478. PubMed ID: 30483773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
